Trillium Therapeutics Inc. (TRIL) Reaches $5.88 After 3.00% Up Move; Washington Prime Group Inc. (WPG) Had 0 Analysts Last Week

June 4, 2018 - By Ellis Scott

Washington Prime Group Inc. (NYSE:WPG) Logo

The stock of Trillium Therapeutics Inc. (NASDAQ:TRIL) is a huge mover today! The stock increased 7.48% or $0.41 during the last trading session, reaching $5.88. About 54,996 shares traded. Trillium Therapeutics Inc. (NASDAQ:TRIL) has risen 11.93% since June 4, 2017 and is uptrending. It has underperformed by 0.64% the S&P500.The move comes after 5 months positive chart setup for the $79.69 million company. It was reported on Jun, 4 by Barchart.com. We have $6.06 PT which if reached, will make NASDAQ:TRIL worth $2.39 million more.

Among 5 analysts covering WP Glimcher (NYSE:WPG), 0 have Buy rating, 1 Sell and 4 Hold. Therefore 0 are positive. WP Glimcher had 9 analyst reports since January 6, 2016 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, January 6 by Goldman Sachs. As per Friday, January 22, the company rating was downgraded by Suntrust Robinson. On Friday, July 15 the stock rating was downgraded by Goldman Sachs to “Neutral”. The rating was maintained by SunTrust with “Hold” on Monday, January 22. The firm has “Underperform” rating given on Wednesday, August 23 by Boenning \u0026 Scattergood. The stock of Washington Prime Group Inc. (NYSE:WPG) has “Hold” rating given on Friday, July 28 by Boenning & Scattergood. The stock of Washington Prime Group Inc. (NYSE:WPG) earned “Neutral” rating by Boenning & Scattergood on Wednesday, April 6. The rating was downgraded by SunTrust to “Neutral” on Friday, January 22. See Washington Prime Group Inc. (NYSE:WPG) latest ratings:

22/01/2018 Broker: SunTrust Rating: Hold New Target: $7.5 Maintain

The stock increased 0.95% or $0.07 during the last trading session, reaching $7.41. About 1.32M shares traded. Washington Prime Group Inc. (NYSE:WPG) has declined 7.49% since June 4, 2017 and is downtrending. It has underperformed by 20.06% the S&P500.

Another recent and important Washington Prime Group Inc. (NYSE:WPG) news was published by Globenewswire.com which published an article titled: “Washington Prime Group Board of Directors Declares Quarterly Dividend” on May 17, 2018.

Washington Prime Group Inc. (NYSE:W

Analysts await Trillium Therapeutics Inc. (NASDAQ:TRIL) to report earnings on August, 10. They expect $-0.66 EPS, up 33.33% or $0.33 from last year’s $-0.99 per share. After $-0.51 actual EPS reported by Trillium Therapeutics Inc. for the previous quarter, Wall Street now forecasts 29.41% negative EPS growth.

Trillium Therapeutics Inc., a clinical-stage immuno-oncology company, develops therapies for the treatment of cancer. The company has market cap of $79.69 million. The companyÂ’s lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase I clinical trial for advanced hematologic malignancies and solid tumors therapy. It currently has negative earnings. The Company’s product candidates also include TTI-622, an IgG4 SIRPaFc protein for combination therapy; bromodomain inhibitor; and epidermal growth factor receptor antagonist, which are in preclinical development stage, as well as undisclosed immuno-oncology targets that are in the discovery Phase.

Trillium Therapeutics Inc. (NASDAQ:TRIL) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>